Group One Trading
BCYC

Group One Trading’s Bicycle Therapeutics BCYC Stock Holding History

Group One Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66K Sell
1,100
-13,500
-92% -$61.9K ﹤0.01% 6769
2026
Q1 		$67.7K Buy
+14,600
New +$83.4K ﹤0.01% 5039
2025
Q4 		– Sell
-12,000
Closed -$92.9K – 8144
2025
Q3 		$92.9K Buy
12,000
+9,800
+445% +$74K ﹤0.01% 5411
2025
Q2 		$15.3K Buy
+2,200
New +$17.5K ﹤0.01% 6439
2025
Q1 		– Sell
-4,200
Closed -$58.8K – 7589
2024
Q4 		$58.8K Sell
4,200
-5,500
-57% -$118K ﹤0.01% 4937
2024
Q3 		$220K Buy
9,700
+9,200
+1,840% +$212K ﹤0.01% 3525
2024
Q2 		$10.1K Buy
500
+400
+400% +$9.04K ﹤0.01% 5638
2024
Q1 		$2.49K Sell
100
-1,900
-95% -$40.4K ﹤0.01% 6439
2023
Q4 		$36.2K Buy
2,000
+1,100
+122% +$18.2K ﹤0.01% 5315
2023
Q3 		$18.1K Sell
900
-1,600
-64% -$36.6K ﹤0.01% 5954
2023
Q2 		$63.8K Buy
+2,500
New +$58.1K ﹤0.01% 5051
2022
Q4 		– Sell
-700
Closed -$16K – 7230
2022
Q3 		$16K Sell
700
-2,400
-77% -$57.1K ﹤0.01% 6207
2022
Q2 		$52K Buy
+3,100
New +$65.4K ﹤0.01% 5511
2022
Q1 		– Sell
-100
Closed -$6K – 8019
2021
Q4 		$6K Buy
+100
New +$5.52K ﹤0.01% 7565

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Group One Trading's BCYC Position: Q2 2026 in Review

Group One Trading opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 1,938 shares worth $8.22K. The stake represents ﹤0.01% of the portfolio and ranks #6518 among its holdings. This is a return to the name: Group One Trading previously reported a position in BCYC as recently as Q2 2025.

Group One Trading first reported a position in BCYC in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.14M in Q2 2023. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Group One Trading held 1,938 shares of Bicycle Therapeutics worth $8.22K as of Q2 2026.
  • Bicycle Therapeutics was a new Group One Trading position in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6518 holding.
  • Group One Trading first reported a position in Bicycle Therapeutics in Q4 2022 and has held it in 10 quarters since.
  • Group One Trading's Bicycle Therapeutics position peaked at $2.14M in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.